Health Canada has approved a second generic Ozempic, and Apotex will manufacture it
Canada is the first G7 country to approve a generic version of a semaglutide
Health Canada announced today that it has authorized a second generic version of Ozempic.
Apotex, a Canada-based global pharmaceutical company and the largest manufacturer of generic drugs in the country, will make it. (Apotex was founded by Barry Sherman. In 2017, he and his wife, Honey Sherman, were murdered in their Toronto home. The case remains unsolved.)
Related: A Toronto convenience store has been selling fake Viagra
“Health Canada authorized the drug after a thorough review of evidence provided by the company demonstrated that the drug meets Health Canada’s criteria for safety, efficacy and quality for generic drugs. Like existing products, this semaglutide injection is indicated for the once-weekly treatment of adult patients with Type 2 diabetes to manage blood sugar levels,” said Health Canada’s statement, published today.
Health Canada recently approved the first generic semaglutide. That one is being manufactured by India’s Dr. Reddy’s Laboratories.
Canada is the first G7 country to approve a generic semaglutide.
Related: Health Canada has issued a recall for gummy bear-shaped Shein magnets
Carly Lewis is a journalist whose work has appeared in the New York Times and the New York Times Magazine, Vanity Fair, Wired, Interview Magazine, Pitchfork, Elle, and Maclean’s, where she is a contributing editor. Her work has been recognized by the National Magazine Awards and the Digital Publishing Awards. She reports on city life, culture—including what people do online—politics, art and crime. She received the Dave Greber Freelance Writers Award for “The Murder of Ashley Wadsworth,” an investigative feature about a Canadian teenager who was killed by a man she met on social media, published by Maclean’s.
